13,181$
0,16%
Echtzeit-Aktienkurs Takeda Pharmaceutical Co. Ltd. (ADRs)
Bid:
Ask:
Echtzeit-Chart der Takeda Pharmaceutical Co. Ltd. (ADRs) Aktie
Börsenkurse Takeda Pharmaceutical Co. Ltd. (ADRs)
| Tradegate | - | - | - | - | 12,400€ | 0,40% |
| Echtzeit USD | - | - | - | - | 13,181$ | 0,16% |
| Börse Stuttgart | - | - | - | - | 12,200€ | -0,81% |
| gettex | - | - | - | - | 12,400€ | 0,00% |
| Börse Frankfurt | - | - | - | - | 12,450€ | 2,89% |
| New York | - | - | - | - | 13,245$ | 0,65% |
| Echtzeit Euro | - | - | - | - | 12,400€ | 2,48% |
Fundamentaldaten der Takeda Pharmaceutical Co. Ltd. (ADRs) Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 29,72 Mrd. | 2,83 Mrd. | 2,34 Mrd. | 0,75 | 4,21% | 17,48 | 1,38 |
| 2022 [USD] | 31,76 Mrd. | 2,83 Mrd. | 2,05 Mrd. | 0,66 | 4,72% | 20,12 | 1,29 |
| 2021 [USD] | 30,15 Mrd. | 3,45 Mrd. | 3,55 Mrd. | 1,14 | 5,88% | 11,61 | 1,37 |
| 2020 [USD] | 30,27 Mrd. | -558,78 Mio. | 406,90 Mio. | 0,13 | 4,84% | 100,62 | 1,36 |
| 2019 [USD] | 18,91 Mrd. | 855,73 Mio. | 984,05 Mio. | 0,51 | 5,00% | 25,74 | 2,17 |
| 2018 [USD] | 15,97 Mrd. | 1,96 Mrd. | 1,69 Mrd. | 1,08 | 4,57% | 12,20 | 1,29 |
| 2017 [USD] | 15,99 Mrd. | 1,32 Mrd. | 1,06 Mrd. | 0,68 | 4,88% | 19,41 | 1,29 |
| 2016 [USD] | 15,05 Mrd. | 1,00 Mrd. | 667,58 Mio. | 0,43 | 4,56% | 30,94 | 1,37 |
| 2015 [USD] | 16,18 Mrd. | -1,32 Mrd. | -1,33 Mrd. | -0,84 | 4,68% | - | 1,28 |
| 2014 [USD] | 16,89 Mrd. | 1,59 Mrd. | 1,06 Mrd. | 0,67 | 6,11% | 19,56 | 1,23 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Takeda Pharmaceutical Co. Ltd. (ADRs) Aktie
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.